Madrigal Pharmaceuticals, Inc. (LON:0JXI)

Madrigal Pharmaceuticals Statistics

Total Valuation

LON:0JXI has a market cap or net worth of GBP 7.39 billion. The enterprise value is 6.91 billion.

Market Cap	7.39B
Enterprise Value	6.91B

Important Dates

The last earnings date was Thursday, February 19, 2026.

Earnings Date	Feb 19, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	22.94M
Shares Outstanding	n/a
Shares Change (YoY)	+5.46%
Shares Change (QoQ)	+1.54%
Owned by Insiders (%)	8.52%
Owned by Institutions (%)	70.31%
Float	12.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.37
PB Ratio	16.49
P/TBV Ratio	16.70
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-32.27
EV / Sales	9.67
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-48.95

Financial Position

The company has a current ratio of 4.01, with a Debt / Equity ratio of 0.58.

Current Ratio	4.01
Quick Ratio	3.60
Debt / Equity	0.58
Debt / EBITDA	n/a
Debt / FCF	-1.83
Interest Coverage	-13.45

Financial Efficiency

Return on equity (ROE) is -42.49% and return on invested capital (ROIC) is -20.56%.

Return on Equity (ROE)	-42.49%
Return on Assets (ROA)	-16.30%
Return on Invested Capital (ROIC)	-20.56%
Return on Capital Employed (ROCE)	-31.61%
Weighted Average Cost of Capital (WACC)	-0.84%
Revenue Per Employee	778,244
Profits Per Employee	-234,093
Employee Count	915
Asset Turnover	0.83
Inventory Turnover	1.03

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +31.50% in the last 52 weeks. The beta is -0.96, so LON:0JXI's price volatility has been lower than the market average.

Beta (5Y)	-0.96
52-Week Price Change	+31.50%
50-Day Moving Average	488.40
200-Day Moving Average	430.01
Relative Strength Index (RSI)	39.70
Average Volume (20 Days)	62

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	10.74

Income Statement

In the last 12 months, LON:0JXI had revenue of GBP 712.09 million and -214.20 million in losses. Loss per share was -9.55.

Revenue	712.09M
Gross Profit	670.38M
Operating Income	-222.97M
Pretax Income	-214.20M
Net Income	-214.20M
EBITDA	-221.85M
EBIT	-222.97M
Loss Per Share	-9.55

Balance Sheet

The company has 730.78 million in cash and 258.29 million in debt, with a net cash position of 472.50 million.

Cash & Cash Equivalents	730.78M
Total Debt	258.29M
Net Cash	472.50M
Net Cash Per Share	n/a
Equity (Book Value)	447.80M
Book Value Per Share	19.60
Working Capital	695.06M

Cash Flow

In the last 12 months, operating cash flow was -140.84 million and capital expenditures -346,981, giving a free cash flow of -141.18 million.

Operating Cash Flow	-140.84M
Capital Expenditures	-346,981
Free Cash Flow	-141.18M
FCF Per Share	n/a

Margins

Gross margin is 94.14%, with operating and profit margins of -31.31% and -30.08%.

Gross Margin	94.14%
Operating Margin	-31.31%
Pretax Margin	-30.08%
Profit Margin	-30.08%
EBITDA Margin	-31.16%
EBIT Margin	-31.31%
FCF Margin	n/a

Dividends & Yields

LON:0JXI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.46%
Shareholder Yield	-5.46%
Earnings Yield	-2.90%
FCF Yield	-1.91%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0JXI has an Altman Z-Score of 6.26 and a Piotroski F-Score of 2.

Altman Z-Score	6.26
Piotroski F-Score	2